Cargando…

Serum Fatty Acid-Binding Protein 4 is Increased in Patients with Psoriasis

Psoriasis is associated with metabolic syndrome and cardiovascular disease. Fatty acid-binding proteins (FABP) have been recognized as predictors of these systemic disorders. The aim of this study was to assess correlations between levels of serum heart and adipocyte fatty acid-binding proteins (FAB...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baran, A., Świderska, M., Bacharewicz-Szczerbicka, Joanna, Myśliwiec, H., Flisiak, I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5222907/ https://www.ncbi.nlm.nih.gov/pubmed/27864793 http://dx.doi.org/10.1007/s11745-016-4211-4

Ejemplares similares

Serum fatty acid profile in psoriasis and its comorbidity
por: Myśliwiec, Hanna, et al.
Publicado: (2017)

Liver fatty acid-binding protein might be a predictive marker of clinical response to systemic treatment in psoriasis
por: Baran, Anna, et al.
Publicado: (2019)

Fatty Acid-Binding Proteins in Psoriasis—A Review
por: Nowowiejska, Julia, et al.
Publicado: (2022)

Paraphenylenediamine and related chemicals as allergens responsible for allergic contact dermatitis
por: Bacharewicz-Szczerbicka, Joanna, et al.
Publicado: (2019)

Serum fatty acid binding protein 5 (FABP5) as a potential biomarker of inflammation in psoriasis
por: Kozłowska, Dorota, et al.
Publicado: (2021)

Effect of psoriasis activity on serum adiponectin and leptin levels
por: Baran, Anna, et al.
Publicado: (2015)

Osteopontin and Regulatory T Cells in Effector Phase of Allergic Contact Dermatitis
por: Reduta, Teresa, et al.
Publicado: (2023)

Abnormal serum fatty acid profile in psoriatic arthritis
por: Mysliwiec, Hanna, et al.
Publicado: (2019)

Crosstalk between Serum and Skin Sphingolipids in Psoriasis
por: Matwiejuk, Mateusz, et al.
Publicado: (2023)

The Role of Sphingolipids in the Pathogenesis of Psoriasis
por: Matwiejuk, Mateusz, et al.
Publicado: (2022)

Kynurenine Pathway in Psoriasis—a Promising Link?
por: Stepaniuk, A., et al.
Publicado: (2023)

Effects of Hypolipidemic Drugs on Psoriasis
por: Matwiejuk, Mateusz, et al.
Publicado: (2023)

Serum Cholesteryl Ester Transfer Protein (CETP) and Sortilin (SORT) in Patients with Psoriasis with Relation to Systemic Treatment
por: Nowowiejska, Julia, et al.
Publicado: (2022)

Aberrations in Lipid Expression and Metabolism in Psoriasis
por: Nowowiejska, Julia, et al.
Publicado: (2021)

Psoriasis and neurodegenerative diseases—a review
por: Nowowiejska, Julia, et al.
Publicado: (2022)

Higher Serum Selenoprotein P Level as a Novel Inductor of Metabolic Complications in Psoriasis
por: Baran, Anna, et al.
Publicado: (2020)

Tumor Necrosis Factor (TNF) α, Endothelin (ET) 1 and α1-Acid Glycoprotein (AGP) as Potential Urine and Serum Markers of Metabolic Complications in Psoriasis?
por: Nowowiejska, Julia, et al.
Publicado: (2023)

Increase in circulating sphingosine-1-phosphate and decrease in ceramide levels in psoriatic patients
por: Myśliwiec, Hanna, et al.
Publicado: (2016)

Effect of methotrexate treatment on the expression of epidermal-fatty acid-binding protein (E-FABP) and apolipoproteins in patients with psoriasis
por: Owczarczyk-Saczonek, Agnieszka, et al.
Publicado: (2020)

Fatty Acid-Binding Protein 7 (FABP-7), Glutamic Acid and Neurofilament Light Chain (NFL) as Potential Markers of Neurodegenerative Disorders in Psoriatic Patients—A Pilot Study
por: Nowowiejska, Julia, et al.
Publicado: (2022)

Mutual Relationship Between Sleep Disorders, Quality of Life and Psychosocial Aspects in Patients With Psoriasis
por: Nowowiejska, Julia, et al.
Publicado: (2021)

Potential Predictive Value of Serum Pentraxin 3 and Paraoxonase 1 for Cardiometabolic Disorders Development in Patients with Psoriasis—Preliminary Data
por: Baran, Anna, et al.
Publicado: (2022)

Intestinal Fatty Acid Binding Protein, a Biomarker of Intestinal Barrier, is Associated with Severity of Psoriasis
por: Sikora, Mariusz, et al.
Publicado: (2019)

Serum adipocyte fatty acid-binding protein in the critically ill
por: Das, Undurti N
Publicado: (2013)

The Potential Role of Serum Tau Protein (MAPT), Neuronal Cell Adhesion Molecule (NrCAM) and Neprilysin (NEP) in Neurodegenerative Disorders Development in Psoriasis—Preliminary Results
por: Baran, Anna, et al.
Publicado: (2022)

Angiopoietin-Like 4 (ANGPTL4) in Patients with Psoriasis, Lichen Planus and Vitiligo—A Pilot Study from the Bialystok+ Polish Longitudinal University Study
por: Nowowiejska, Julia, et al.
Publicado: (2022)

Psoriasis: Obesity and Fatty Acids
por: Kunz, Manfred, et al.
Publicado: (2019)

Gasdermin E (GSDME)—A New Potential Marker of Psoriasis and Its Metabolic Complications: The First Combined Study on Human Serum, Urine and Tissue
por: Nowowiejska, Julia, et al.
Publicado: (2023)

Two methods for increasing sensitivity of dobutamine stress echocardiography: strain imaging and heart-type fatty acid-binding protein levels
por: Çalapkorur, Bekir, et al.
Publicado: (2016)

Assessment of Life Quality, Stress and Physical Activity Among Patients with Psoriasis
por: Nowowiejska, Julia, et al.
Publicado: (2021)

Correlation between Serum Fatty Acid Binding Protein 4 (FABP4) Levels and Cardiac Function in Patients with Thalassemia Major
por: Fianza, Pandji I., et al.
Publicado: (2021)

Decreased levels of vaspin and its potential association with cardiometabolic risk in patients with psoriasis: preliminary results
por: Kiluk, Paulina, et al.
Publicado: (2021)

Evidence that Chemical Chaperone 4-Phenylbutyric Acid Binds to Human Serum Albumin at Fatty Acid Binding Sites
por: Roy, Debasish, et al.
Publicado: (2015)

Evaluation of Plasma Concentrations of Galectins-1, 2 and 12 in Psoriasis and Their Clinical Implications
por: Nowowiejska, Julia, et al.
Publicado: (2023)

Elevated circulating Krüppel-like factor 4 level as a novel independent marker of the proatherogenic risk in patients with psoriasis: a preliminary study
por: Baran, Anna, et al.
Publicado: (2020)

The interplay between Th17 and T-regulatory responses as well as adipokines in the progression of non-alcoholic fatty liver disease
por: Świderska, Magdalena, et al.
Publicado: (2017)

Fatty Acid-Binding Protein 4 in Cardiovascular and Metabolic Diseases
por: Furuhashi, Masato
Publicado: (2019)

The adipokine fatty-acid binding protein 4 and cardiac remodeling
por: von Jeinsen, Beatrice, et al.
Publicado: (2020)

Circulating ANGPTL8 as a Potential Protector of Metabolic Complications in Patients with Psoriasis
por: Baran, Anna, et al.
Publicado: (2023)

Relationship Between Fatty Acid Binding Protein 4 and Liver Fat in Individuals at Increased Cardiometabolic Risk
por: Rodríguez-Calvo, Ricardo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_omks7a48mg7ogf8p3cok8kui7v